We've found
184,457
clinical trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Ophthalmology Clinical Trial
Cross-linking for Corneal Ulcers Treatment Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Onalespib in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Status: Enrolling,
Phase
III
Updated: 7/28/2016
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplastic Disease Clinical Trial
QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Depression Clinical Trial
Low Pulse Amplitude Focal ECT (LAP Study)
Status: Enrolling
Updated: 3/25/2018
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
Status: Enrolling,
Phase
I, II
Updated: 12/26/2017
Click here to add this to my saved trials
ALK Positive Malignancies Clinical Trial
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
We've found
184,457
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Cross-linking for Corneal Ulcers Treatment Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 2/29/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 2/29/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Onalespib in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
Updated: 12/31/1969
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 7/28/2016
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Status: Enrolling,
Phase
III
Updated: 7/28/2016
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
Updated: 12/31/1969
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
Updated: 12/31/1969
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplastic Disease Clinical Trial
Updated: 12/31/1969
QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia (CLL) Clinical Trial
Updated: 12/31/1969
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Depression Clinical Trial
Updated: 3/25/2018
Low Pulse Amplitude Focal ECT (LAP Study)
Status: Enrolling
Updated: 3/25/2018
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/26/2017
Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
Status: Enrolling,
Phase
I, II
Updated: 12/26/2017
Click here to add this to my saved trials
ALK Positive Malignancies Clinical Trial
Updated: 12/31/1969
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Arteritic Anterior Ischemic Optic Neuropathy Clinical Trial
Updated: 12/31/1969
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 8/16/2016
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling,
Phase
IV
Updated: 8/16/2016
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Efficacy Study Of Tofacitinib In Pediatric JIA Population
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 2/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 2/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 2/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 2/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 2/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 2/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling,
Phase
II
Updated: 2/28/2016
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 6/28/2016
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 6/28/2016
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 6/28/2016
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 6/28/2016
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Colorectal Carcinoma Clinical Trial
Updated: 6/28/2016
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)
Status: Enrolling,
Phase
II
Updated: 6/28/2016
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Updated: 12/31/1969
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Updated: 12/31/1969
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Updated: 12/31/1969
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 5/31/2017
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 5/31/2017
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 5/31/2017
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 5/31/2017
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 5/31/2017
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 5/31/2017
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling,
Phase
III
Updated: 5/31/2017
Click here to add this to my saved trials